Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing

Authors

  • Smt. S. Sri Chamundeswari Devi Author
  • Mr. B.V. Narasimaha Roy Author
  • Mr. K.Ravi kanth Author
  • Ms. M.Sri vidhya Author

Abstract

Globally, 455,000 new cases of multidrug-resistant TB (MDR)—defined as Mycobacterium tuberculosis
resistant to at least isoniazid and rifampicin—occurred in 2012, according to the World Health Organisation
(WHO).1 There isn't much proof that multidrug-resistant TB patients are more contagious than completely
sensitive tuberculosis patients, but the longer time these patients are infectious means more chances for
transmission

Downloads

Published

2023-08-15

Issue

Vol. 20 No. 3 (2023): volume 20 issue 3 2023

Section

Articles

License

Copyright (c) 2023 Smt. S. Sri Chamundeswari Devi, Mr. B.V. Narasimaha Roy, Mr. K.Ravi kanth, Ms. M.Sri vidhya (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. (2023). Indo-American Journal of Life Sciences and Biotechnology, 20(3), 1-13. https://iajlb.org/index.php/iajlb/article/view/162